Astigmatism is one of the most common reasons people struggle with clear vision, and many are curious if EVO ICL can help. The good news is that this implantable lens isn’t just for nearsightedness—it can also be used to correct certain levels of astigmatism. Read on to learn how EVO ICL works for astigmatism and who may benefit. Schedule a consultation with Brinton Vision to find out if EVO ICL is the right solution for you.
Can EVO ICL treat astigmatism?
Yes, EVO ICL can effectively treat astigmatism as well as myopia, giving Brinton Vision patients a clear alternative to glasses or contact lens wear. This refractive surgery, widely used in ophthalmology, involves placing a custom, biocompatible implant between the iris and the natural lens, where it corrects the refractive error without altering corneal tissue. In astigmatism, the cornea’s curvature is uneven, causing light to focus in multiple points instead of one. The toric lens design of EVO ICL is engineered with varying powers in different meridians, which offsets this irregular shape and brings light into sharp focus on the retina. The lens is tailored to each eyeglass prescription, addressing the exact amount of astigmatism for the individual patient. Many see an immediate improvement in visual acuity after this eye surgery, often within days of the procedure. Because EVO ICL leaves the cornea intact, it is a strong option for those who are not LASIK candidates due to thin corneas, near-sightedness, dry eye syndrome, or other concerns.
Can EVO ICL fully correct high levels of astigmatism?
EVO ICL can correct astigmatism up to 4.0 diopters, covering most mild to moderate cases and some higher prescriptions. Within this range, results are excellent, often eliminating the need for a corrective lens entirely. The lens remains in a fixed position inside the eye, which keeps the correction stable over time as long as the prescription is stable. For patients with astigmatism above this limit, or irregular corneal shapes found through corneal topography, additional procedures or combination therapy may be required to achieve optimal visual acuity. Brinton Vision uses detailed eye examinations to determine each candidate’s suitability, considering prescription, corneal shape, and overall eye health. This personalized approach helps reduce the risk of complication while delivering the best possible outcome.
Are you ready to take the next step in your vision journey?
How does EVO ICL compare to LASIK for astigmatism correction?
EVO ICL and LASIK are both established refractive surgery options for astigmatism, but they differ in technique, candidate selection, and flexibility. LASIK uses a laser to reshape corneal tissue, permanently changing its shape to improve visual perception, while EVO ICL places an intraocular lens inside the human eye without removing tissue. EVO ICL is reversible, offers lower risk of dry eye syndrome, and often delivers superior night vision quality—particularly for patients with astigmatism who may have experienced starbursts, halos, or ghosting in low light before surgery. It is particularly well-suited for patients with thin corneas, higher prescriptions, or dry eye concerns, while LASIK remains a popular choice for those with healthy corneas and mild to moderate astigmatism. At Brinton Vision, personalization is key—each patient’s anatomy, prescription, and lifestyle goals are evaluated during the comprehensive diagnostic exam to select the right option.
Are there limitations on astigmatism degrees treated by EVO ICL?
Yes, EVO ICL has Food and Drug Administration–approved treatment parameters in the United States, correcting astigmatism from 1.0 to 4.0 diopters and myopia up to -20.0 D. This makes it an effective choice for most patients but not for extremely high or irregular astigmatism, farsightedness, or advanced eye conditions such as uncontrolled glaucoma or cataract. The lens is made from a collagen-based crystal material designed for biocompatibility, providing ultraviolet protection while remaining in place indefinitely. EVO Visian ICL is placed during surgery under local anesthesia, with eye drop use before and after the procedure to support healing. A comprehensive diagnostic exam at Brinton Vision includes a full discussion of safety, healing expectations, and moderation of any pre-existing eye pressure concerns to ensure the procedure is the right fit.
Clear Vision Starts Here
EVO ICL offers a proven, precise option for correcting astigmatism within its approved range, with the added benefits of reversibility, biocompatibility, and high-quality visual outcomes. It is especially valuable for patients who are not candidates for LASIK due to corneal thickness, near-sightedness, or dry eye syndrome. Brinton Vision combines advanced diagnostic technology with a personalized treatment plan to match each patient with the safest, most effective option for their vision goals. If you are considering EVO ICL to treat your astigmatism, schedule a consultation with Brinton Vision to find out if you are a candidate and take the first step toward clearer vision.
https://us.discovericl.com/faq
